471 related articles for article (PubMed ID: 22541243)
1. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
2. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
3. B-cell subsets, signaling and their roles in secretion of autoantibodies.
Iwata S; Tanaka Y
Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
[TBL] [Abstract][Full Text] [Related]
4. Syk is indispensable for CpG-induced activation and differentiation of human B cells.
Kremlitzka M; Mácsik-Valent B; Erdei A
Cell Mol Life Sci; 2015 Jun; 72(11):2223-36. PubMed ID: 25543269
[TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
6. Syk mediates BCR- and CD40-signaling integration during B cell activation.
Ying H; Li Z; Yang L; Zhang J
Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
[TBL] [Abstract][Full Text] [Related]
7. Autoinhibition and adapter function of Syk.
Kulathu Y; Grothe G; Reth M
Immunol Rev; 2009 Nov; 232(1):286-99. PubMed ID: 19909371
[TBL] [Abstract][Full Text] [Related]
8. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.
Vendel AC; Calemine-Fenaux J; Izrael-Tomasevic A; Chauhan V; Arnott D; Eaton DL
J Immunol; 2009 Feb; 182(3):1509-17. PubMed ID: 19155498
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
[TBL] [Abstract][Full Text] [Related]
10. Ca(2+) -related signaling events influence TLR9-induced IL-10 secretion in human B cells.
Ziegler S; Gartner K; Scheuermann U; Zoeller T; Hantzschmann J; Over B; Foermer S; Heeg K; Bekeredjian-Ding I
Eur J Immunol; 2014 May; 44(5):1285-98. PubMed ID: 24470136
[TBL] [Abstract][Full Text] [Related]
11. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
[TBL] [Abstract][Full Text] [Related]
12. [Involvement of Syk in pathology of systemic autoimmune disease].
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Saito K; Akashi K; Tanaka Y
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):56-61. PubMed ID: 22374444
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
Lin YC; Huang DY; Chu CL; Lin WW
Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
[TBL] [Abstract][Full Text] [Related]
17. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
18. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
Simchoni N; Cunningham-Rundles C
J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-induced IgG production in TLR-activated human primary B cells involves ULK1-mediated autophagy.
Eriksen AB; Torgersen ML; Holm KL; Abrahamsen G; Spurkland A; Moskaug JØ; Simonsen A; Blomhoff HK
Autophagy; 2015; 11(3):460-71. PubMed ID: 25749095
[TBL] [Abstract][Full Text] [Related]
20. CD19 controls Toll-like receptor 9 responses in human B cells.
Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
